A 3′-UTR
KRAS
-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Figure 1
- eps file
Supplementary Figure 2
- eps file
Supplementary Tables
- docx file